GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2007

DoD Taps Ichor for Biodefense Vaccine

  • Ichor Medical Systems was awarded a two-year contract valued at over $900,000 to develop a DNA vaccine for equine encephalitis. The funding from the DoD extends Ichor's existing relationship with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

    According to CEO Bob Bernard, Ichor will collaborate with Connie Schmaljohn, senior research scientist at USAMRIID, to evaluate an array of vaccine candidates administered using Ichor's TriGrid DNA vaccine delivery system. 

    "Ichor's TriGrid Delivery System dramatically enhances the magnitude and consistency of immune responses following DNA vaccination, both of which have a critical role in vaccine efficacy,” states Bernard.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?